440 related articles for article (PubMed ID: 11463877)
1. Public health. Responding to market failures in tuberculosis control.
Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
[No Abstract] [Full Text] [Related]
2. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
3. How to ensure the continued resurgence of tuberculosis.
Reichman LB
Lancet; 1996 Jan; 347(8995):175-7. PubMed ID: 8544556
[No Abstract] [Full Text] [Related]
4. [Tuberculosis in the 21st centruy].
Casal M
Enferm Infecc Microbiol Clin; 2000 May; 18(5):207-8. PubMed ID: 10974762
[No Abstract] [Full Text] [Related]
5. Drug-resistant tuberculosis: desperate measures?
Cullinan T
Lancet; 2001 Apr; 357(9262):1124. PubMed ID: 11297986
[No Abstract] [Full Text] [Related]
6. TB drug prices slashed for poor countries.
Hagmann M
Bull World Health Organ; 2001; 79(9):904-5. PubMed ID: 11584747
[No Abstract] [Full Text] [Related]
7. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
Lobato MN; Jereb JA; Castro KG
Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
[No Abstract] [Full Text] [Related]
8. [Concerning tuberculosis].
Sante; 2000; 10(5):362-3. PubMed ID: 11221699
[No Abstract] [Full Text] [Related]
9. Cost-effective control of drug-resistant TB: listening to other voices.
Portero JL; Rubio M
PLoS Med; 2006 Dec; 3(12):e542. PubMed ID: 17194207
[No Abstract] [Full Text] [Related]
10. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
Atre SR; Mistry NF
J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis as an international and national problem].
Khomenko AG
Probl Tuberk; 1994; (2):2-4. PubMed ID: 8036208
[No Abstract] [Full Text] [Related]
12. [Tuberculosis].
Günther G; Heyckendorf J; Herzmann C; Lange C
Dtsch Med Wochenschr; 2012 May; 137(18):947-58; quiz 959-62. PubMed ID: 22538419
[TBL] [Abstract][Full Text] [Related]
13. Response to drug resistant tuberculosis is insufficient and too slow.
Cui W
BMJ; 2011 Mar; 342():d1969. PubMed ID: 21444638
[No Abstract] [Full Text] [Related]
14. Antimicrobial resistance in tuberculosis: an international perspective.
van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis: antibiotic resistances, more than ever a menace].
Nau JY
Rev Med Suisse; 2012 Sep; 8(353):1746-7. PubMed ID: 23029990
[No Abstract] [Full Text] [Related]
16. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
Keshavjee S; Farmer PE
N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
[No Abstract] [Full Text] [Related]
17. Curing multidrug-resistant tuberculosis: not all about the money.
Gruber K
Lancet Respir Med; 2016 Nov; 4(11):870-871. PubMed ID: 27799128
[No Abstract] [Full Text] [Related]
18. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
Denholm J
J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
[No Abstract] [Full Text] [Related]
19. Tuberculosis control goals unlikely to be met by 2005.
Sharma DC
Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
[No Abstract] [Full Text] [Related]
20. Implementation of fixed-dose combinations in tuberculosis control: outline of responsibilities.
Chaulet P
Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S353-7; discussion S381-7. PubMed ID: 10593717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
